Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
Kattamis
C A
CA
1st Department of Pediatrics, Medical School, University of Athens, St. Sophia Children's Hospital, Greece.
Kattamis
A C
AC
D000293:Adolescent; D000328:Adult; D001361:Avitaminosis / Q000209:etiology / Q000517:prevention & control; D015913:Chelation Therapy; D002648:Child; D002675:Child, Preschool; D004700:Endocrine System Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005947:Glucose / Q000378:metabolism; D006130:Growth Disorders / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D013006:Growth Hormone / Q000378:metabolism; D006432:Hemochromatosis / Q000209:etiology; D006801:Humans; D007501:Iron; D008297:Male; D011628:Puberty, Delayed / Q000209:etiology / Q000517:prevention & control; D013789:Thalassemia / Q000150:complications / Q000628:therapy*; D065227:Transfusion Reaction; D014611:Vaccination; D014815:Vitamins / Q000627:therapeutic use
D014815:Vitamins; D013006:Growth Hormone; D007501:Iron; D005947:Glucose